Pharmacokinetics and central nervous system effects of the novel dopamine D-3 receptor antagonist GSK598809 and intravenous alcohol infusion at pseudo-steady state

Addictionalcoholdopamine D3 receptorGSK598809interactionpharmacodynamicspharmacokineticssubstance abuse